Zobrazeno 1 - 10 of 13 pro vyhledávání: '"Ricardo Eccard da, Silva"'
1
Akademický článek
The impact of social cohesion and risk communication on excess mortality due to COVID-19 in 213 countries: a retrospective analysis
Autor: Ricardo Eccard da Silva, Maria Rita Carvalho Garbi Novaes, Cesar de Oliveira, Dirce Bellezi Guilhem
Publikováno v: BMC Public Health, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Tools for assessing a country’s capacity in the face of public health emergencies must be reviewed, as they were not predictive of the COVID-19 pandemic. Social cohesion and risk communication, which are related to trust in gove
Externí odkaz: https://doaj.org/article/7953eb56678545ad8b45334c8ffaff83
Zobrazit plný text záznamu
2
Akademický článek
National governance and excess mortality due to COVID-19 in 213 countries: a retrospective analysis and perspectives on future pandemics
Autor: Ricardo Eccard da Silva, Maria Rita Carvalho Garbi Novaes, Cesar de Oliveira, Dirce Bellezi Guilhem
Publikováno v: Globalization and Health, Vol 19, Iss 1, Pp 1-12 (2023)
Abstract Background National governance may have influenced the response of institutions to the Covid-19 pandemic, being a key factor in preparing for the next pandemics. The objective was to analyze the association between excess mortality due to CO
Externí odkaz: https://doaj.org/article/224a7e6c814f422ba63c5d1343253976
Zobrazit plný text záznamu
3
Akademický článek
The High 'Cost' of Experimental Drugs Obtained Through Health Litigation in Brazil
Autor: Ricardo Eccard da Silva, Elisangela da Costa Lima, Maria Rita C. G. Novaes, Claudia G. S. Osorio-de-Castro
Publikováno v: Frontiers in Pharmacology, Vol 11 (2020)
BackgroundBrazilian patients have legal right to access unlicensed medicines undergoing clinical research, if there is evidence of efficacy and safety. This study investigated the occurrence of serious adverse events related to very high-cost medicin
Externí odkaz: https://doaj.org/article/5c87158b64934e6ba3b6d0e19f7053bf
Zobrazit plný text záznamu
4
Comparison of new Brazilian legislation for the approval of advanced therapy medicinal products with existing systems in the USA, European Union and Japan
Autor: Kelly Lucy Guimarães Gomes, Ricardo Eccard da Silva, João Batista da Silva Junior, Maria Rita Carvalho Garbi Novaes
Publikováno v: Cytotherapy. 24:557-566
Advanced therapy medicinal products (ATMPs) are a class of biological products for human use that are based on genes, cells and tissues. The first ATMP received marketing authorization in Europe in 2009, whereas Brazil granted the first authorization
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfca331665fce5947cf516fa39958945
https://doi.org/10.1016/j.jcyt.2021.10.008
Zobrazit plný text záznamu
5
The patient’s safety and access to experimental drugs after the termination of clinical trials: regulations and trends
Autor: Angélica Amorim Amato, Maria Rita Carvalho Garbi Novaes, Thiago do Rêgo Sousa, Marta Rodrigues de Carvalho, Ricardo Eccard da Silva
Publikováno v: European Journal of Clinical Pharmacology. 74:1001-1010
Participants’ rights and safety must be guaranteed not only while a clinical trial is being conducted but also when a clinical trial finishes. The criteria for post-trial access to experimental drugs, however, are unclear in various countries. The
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49e46ca98c31a2852b0f5474c3a0fe21
https://doi.org/10.1007/s00228-018-2474-9
Zobrazit plný text záznamu
6
Risk factors for, and treatment of, Stevens-Johnson syndrome and toxic epidermal necrolysis: Evidence from the literature
Autor: Ricardo Eccard da Silva, Alice Garbi Novaes, Leila Bernarda Donato Göttems, Maria Rita Carvalho Garbi Novaes
Publikováno v: African Journal of Pharmacy and Pharmacology. 12:61-70
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are adverse drug reactions. They occur in the form of mild and sometimes severe cutaneous eruptions, with high morbidity and mortality, requiring fast and appropriate diagnosis and t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::add43cf192ea53971dfc9f910128ee44
https://doi.org/10.5897/ajpp2017.4873
Zobrazit plný text záznamu
7
Incentives and challenges related to technological research and innovation within the Unified Health System in the Federal District of Brazil
Autor: Claudia Cardoso Gomes da Silva, Maria Rita Carvalho Garbi Novaes, Flávia Tavares Silva Elias, Marge Tenorio, Marcia Luz da Motta, Vanessa de Amorim Teixeira Baliero, Ricardo Eccard da Silva
Publikováno v: Ciência & Saúde Coletiva, Volume: 24, Issue: 6, Pages: 2211-2220, Published: 27 JUN 2019
Ciência & Saúde Coletiva v.24 n.6 2019
Ciência & Saúde Coletiva
Associação Brasileira de Saúde Coletiva (ABRASCO)
instacron:ABRASCO
Ciência & Saúde Coletiva, Vol 24, Iss 6, Pp 2211-2220
Resumo O objetivo deste trabalho foi analisar o perfil das pesquisas científicas financiadas no Distrito Federal provenientes das chamadas públicas do Programa Pesquisa para o SUS: Gestão Compartilhada em Saúde (PPSUS/DF) e Programa de Fomento a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53cf58d888d161a456681287a075c85d
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232019000602211&lng=en&tlng=en
Zobrazit plný text záznamu
8
Incentives and challenges related to technological research and innovation within the Unified Health System in the Federal District of Brazil
Autor: Maria Rita Carvalho Garbi, Novaes, Marcia Luz da, Motta, Flavia Tavares Silva, Elias, Ricardo Eccard da, Silva, Claudia Cardoso Gomes da, Silva, Vanessa de Amorim Teixeira, Baliero, Marge, Tenorio
Publikováno v: Cienciasaude coletiva. 24(6)
This article analyzes the profile of research conducted in the Federal District of Brazil funded through public calls for proposals issued by the Research for the SUS Program: shared health management/Federal District (PPSUS/DF) and a research suppor
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3b29b17143e069a044897b0c4781b7ea
https://pubmed.ncbi.nlm.nih.gov/31269180
Zobrazit plný text záznamu
9
Trends in research involving human beings in Brazil
Autor: Ricardo Eccard da Silva, Maria Rita Carvalho Novaes, Elza Martínez Pastor, Elena Barragan, Angélica Amorim Amato
Publikováno v: Revista Panamericana de Salud Pública, Vol 37, Iss 2, Pp 118-124 (2015)
Developing countries have experienced a dramatic increase in the number of clinical studies in the last decades. The aim of this study was to describe 1) the number of clinical trials submitted to the Brazilian Health Surveillance Agency (Agência Na
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b148e87a52e377d6ca5225efd086c4e7
https://pubmed.ncbi.nlm.nih.gov/25915017
Zobrazit plný text záznamu
10
Pharmaceutical innovation and technological dependence: a study of the Brazilian scenario
Autor: Angélica Amorim Amato, Ricardo Eccard da Silva, Maria Rita Carvalho Garbi Novaes
Publikováno v: International Journal of Clinical Trials. 3:15
Background: Among other factors, a country’s pharmaceutical innovation and technological dependence is related to its ability to research and develop technology. Brazil imports pharmaceutical products and drugs, in order to meet the population’s
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b88bdf65584466733bff3749783fdff6
https://doi.org/10.18203/2349-3259.ijct20160474
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje